Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -20.14M
March 31, 2026 -11.21M
December 31, 2025 -18.39M
September 30, 2025 -30.03M
June 30, 2025 187.46M
March 31, 2025 -16.81M
December 31, 2024 -26.55M
September 30, 2024 -22.86M
June 30, 2024 -21.69M
March 31, 2024 -17.86M
December 31, 2023 -30.65M
September 30, 2023 -24.51M
June 30, 2023 -17.61M
March 31, 2023 -15.18M
December 31, 2022 -24.00M
September 30, 2022 -12.53M
June 30, 2022 -5.192M
March 31, 2022 -1.868B
December 31, 2021 -32.94M
September 30, 2021 -21.09M
June 30, 2021 -17.78M
March 31, 2021 -18.88M
December 31, 2020 -40.90M
September 30, 2020 -24.08M
June 30, 2020 -9.684M
Date Value
March 31, 2020 -23.47M
December 31, 2019 -101.00M
September 30, 2019 -23.90M
June 30, 2019 -31.48M
March 31, 2019 -10.51M
December 31, 2018 -19.08M
September 30, 2018 -45.00M
June 30, 2018 -24.27M
March 31, 2018 -15.02M
December 31, 2017 -29.61M
September 30, 2017 -50.96M
June 30, 2017 -12.40M
March 31, 2017 -173.90M
December 31, 2016 100.89M
September 30, 2016 -86.04M
June 30, 2016 0.869M
March 31, 2016 0.56M
December 31, 2015 -36.40M
September 30, 2015 -1.891M
June 30, 2015 7.037M
March 31, 2015 20.02M
December 31, 2014 3.401M
September 30, 2014 -1.823M
June 30, 2014 -11.33M
March 31, 2014 -12.00M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Baxter International, Inc. -117.00M
Haemonetics Corp. -22.23M
Merit Medical Systems, Inc. -110.13M
Teleflex, Inc. -15.51M
Globus Medical, Inc. -129.05M